These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 31504957

  • 1. Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome.
    Ozguler Y, Hatemi G, Cetinkaya F, Tascilar K, Hamuryudan V, Ugurlu S, Seyahi E, Yazici H, Melikoglu M.
    Rheumatology (Oxford); 2020 Apr 01; 59(4):799-806. PubMed ID: 31504957
    [Abstract] [Full Text] [Related]

  • 2. Recurrent Iliofemoral Venous Thrombosis in the Setting of May-Thurner Syndrome as the Presenting Symptom of Behcet's Disease.
    Lakha S, Png CYM, Chun K, Ting W.
    Ann Vasc Surg; 2018 May 01; 49():315.e1-315.e3. PubMed ID: 29481922
    [Abstract] [Full Text] [Related]

  • 3. Congenital absence of inferior vena cava with idiopathic deep vein thrombosis in an adult.
    Hooda D, Penumetsa K, Jackson T, Gharib W, Beto RJ, Warden BE.
    W V Med J; 2013 May 01; 109(2):28-30. PubMed ID: 23600102
    [No Abstract] [Full Text] [Related]

  • 4. Relationship between the site of thrombosis and the prevalence of pulmonary embolism in acute lower extremity deep venous thrombosis.
    Zhang C, Li Q, Yu H, Wang F, Lin Z, Yin W, Pan Y, Wu M, Xie W, Chen X, Liu N.
    J Vasc Surg Venous Lymphat Disord; 2020 Sep 01; 8(5):725-733. PubMed ID: 32063525
    [Abstract] [Full Text] [Related]

  • 5. Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
    Yoshida S, Takeuchi T, Yoshikawa A, Ozaki T, Fujiki Y, Hata K, Makino S, Hanafusa T.
    Mod Rheumatol; 2012 Sep 01; 22(5):791-5. PubMed ID: 22245952
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid in Combination with a TNF-α Inhibitor: Treatment of Deep Vein Thrombosis in a Patient with Behçet's Disease.
    Okano M, Yoneda K, Ichise Y, Kusuhara S, Muramae N, Mori K, Otsui K, Sakaguchi K.
    Intern Med; 2023 Jul 01; 62(13):2009-2012. PubMed ID: 36384897
    [Abstract] [Full Text] [Related]

  • 7. Can anticoagulation therapy in cerebral venous thrombosis associated with Behçet's disease be stopped without relapse?
    Roriz M, Crassard I, Lechtman S, Saadoun D, Champion K, Wechsler B, Chabriat H, Sène D.
    Rev Neurol (Paris); 2018 Mar 01; 174(3):162-166. PubMed ID: 29523353
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunosuppressants reduce venous thrombosis relapse in Behçet's disease.
    Desbois AC, Wechsler B, Resche-Rigon M, Piette JC, Huong Dle T, Amoura Z, Koskas F, Desseaux K, Cacoub P, Saadoun D.
    Arthritis Rheum; 2012 Aug 01; 64(8):2753-60. PubMed ID: 22354392
    [Abstract] [Full Text] [Related]

  • 10. A fatal case of Behcet's disease with rare complications.
    Sahin M, Arslan C, Tunc SE, Yavuz T, Goksu SS.
    Saudi Med J; 2006 Nov 01; 27(11):1754-7. PubMed ID: 17106558
    [Abstract] [Full Text] [Related]

  • 11. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M.
    Am J Gastroenterol; 1997 May 01; 92(5):858-62. PubMed ID: 9149201
    [Abstract] [Full Text] [Related]

  • 12. Extended venous thrombosis in Adamantiades-Behçet's disease.
    Zouboulis CC.
    Eur J Dermatol; 2004 May 01; 14(4):268-71. PubMed ID: 15319164
    [Abstract] [Full Text] [Related]

  • 13. Vascular Behçet's syndrome: an update.
    Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, Prisco D.
    Intern Emerg Med; 2019 Aug 01; 14(5):645-652. PubMed ID: 30499073
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.
    Bodaghi B, Gendron G, Wechsler B, Terrada C, Cassoux N, Huong du LT, Lemaitre C, Fradeau C, LeHoang P, Piette JC.
    Br J Ophthalmol; 2007 Mar 01; 91(3):335-9. PubMed ID: 17050581
    [Abstract] [Full Text] [Related]

  • 15. Budd-Chiari syndrome associated with Behçet's disease.
    Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH.
    Gastroenterol Clin Biol; 2008 Mar 01; 32(3):316-20. PubMed ID: 18400436
    [Abstract] [Full Text] [Related]

  • 16. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
    Hatemi I, Hatemi G, Pamuk ON, Erzin Y, Celik AF.
    Clin Exp Rheumatol; 2015 Mar 01; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
    [Abstract] [Full Text] [Related]

  • 17. Scoping beyond pulmonary artery involvement; pulmonary involvement in Behcet's disease; a retrospective analysis of 28 patients.
    Yıldırım R, Oğuzman S, Dinler M, Bilge NŞY, Kaşifoğlu T.
    Clin Rheumatol; 2023 Mar 01; 42(3):849-853. PubMed ID: 36326947
    [Abstract] [Full Text] [Related]

  • 18. Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments.
    Sobaci G, Erdem U, Durukan AH, Erdurman C, Bayer A, Köksal S, Karagul S, Bayraktar MZ.
    Ophthalmology; 2010 Jul 01; 117(7):1430-5. PubMed ID: 20417563
    [Abstract] [Full Text] [Related]

  • 19. Update on the treatment of Behçet's syndrome.
    Esatoglu SN, Hatemi G.
    Intern Emerg Med; 2019 Aug 01; 14(5):661-675. PubMed ID: 30684097
    [Abstract] [Full Text] [Related]

  • 20. [Progress in interferon: A treatment of Behcet syndrome].
    Yan D, Zheng WJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec 18; 52(6):1166-1170. PubMed ID: 33331331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.